• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化中的黏液结构与特性

Mucus structure and properties in cystic fibrosis.

作者信息

Rubin Bruce K

机构信息

Pediatrics and Biomedical Engineering, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1081, USA.

出版信息

Paediatr Respir Rev. 2007 Mar;8(1):4-7. doi: 10.1016/j.prrv.2007.02.004. Epub 2007 Mar 21.

DOI:10.1016/j.prrv.2007.02.004
PMID:17419972
Abstract

The biophysical properties of airway secretions are largely determined by the polymeric components. In normal airway mucus, the gel-forming mucins, MUC5AC and MUC5B, are responsible not only for the viscoelastic properties essential for clearance and protecting the airway epithelium from invaders and water evaporation. With chronic airway infection, inflammatory cell necrosis leads to a predominance of polymeric DNA and F-actin. There is almost no mucin in the sputum of patients with established cystic fibrosis lung disease. Sputum viscoelastic and surface properties determine how well secretions can be cleared by cilia or cough. In this mini-Symposium on Airway Clearance in Cystic Fibrosis, the physiology of CF secretion structure and rheology is discussed in the context of medications and physical maneuvers for enhancing sputum clearance.

摘要

气道分泌物的生物物理特性很大程度上由聚合物成分决定。在正常气道黏液中,形成凝胶的黏蛋白MUC5AC和MUC5B不仅负责维持黏液的黏弹性,这种特性对于清除气道分泌物、保护气道上皮免受病原体入侵以及防止水分蒸发至关重要。慢性气道感染时,炎症细胞坏死导致聚合物DNA和F-肌动蛋白占主导。在已确诊的囊性纤维化肺病患者的痰液中几乎没有黏蛋白。痰液的黏弹性和表面特性决定了分泌物通过纤毛运动或咳嗽清除的效果。在本次关于囊性纤维化气道清除的小型研讨会上,将在促进痰液清除的药物和物理手段的背景下讨论囊性纤维化分泌物的结构和流变学生理。

相似文献

1
Mucus structure and properties in cystic fibrosis.囊性纤维化中的黏液结构与特性
Paediatr Respir Rev. 2007 Mar;8(1):4-7. doi: 10.1016/j.prrv.2007.02.004. Epub 2007 Mar 21.
2
Physiology of airway mucus clearance.气道黏液清除的生理学
Respir Care. 2002 Jul;47(7):761-8.
3
MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.黏蛋白MUC5AC和MUC5B在囊性纤维化气道分泌物中减少。
Am J Respir Cell Mol Biol. 2004 Jul;31(1):86-91. doi: 10.1165/rcmb.2003-0345OC. Epub 2004 Feb 26.
4
MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation.在肺部病情加重期间,囊性纤维化气道分泌物中的MUC5AC和MUC5B黏蛋白会增加。
Am J Respir Crit Care Med. 2007 Apr 15;175(8):816-21. doi: 10.1164/rccm.200607-1011OC. Epub 2007 Jan 25.
5
The pharmacologic approach to airway clearance: mucoactive agents.气道廓清的药理学方法:黏液促排剂。
Respir Care. 2002 Jul;47(7):818-22.
6
Mucolytics, expectorants, and mucokinetic medications.黏液溶解剂、祛痰剂和促黏液运动药物。
Respir Care. 2007 Jul;52(7):859-65.
7
CPAP has no effect on clearance, sputum properties, or expectorated volume in cystic fibrosis.持续气道正压通气对囊性纤维化患者的清除率、痰液性质或咳出量没有影响。
Respir Care. 2012 Nov;57(11):1914-9. doi: 10.4187/respcare.01705. Epub 2012 Mar 13.
8
Effect of osmolality on mucociliary transportability and rheology of cystic fibrosis and bronchiectasis sputum.渗透压对囊性纤维化和支气管扩张症痰液的黏液纤毛运输能力及流变学的影响。
Respirology. 2003 Jun;8(2):181-5. doi: 10.1046/j.1440-1843.2003.00454.x.
9
Is cystic fibrosis mucus abnormal?囊性纤维化患者的黏液是否异常?
Pediatr Res. 1981 Feb;15(2):120-2. doi: 10.1203/00006450-198102000-00007.
10
Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients.基因分型囊性纤维化患者呼吸道黏液的物理化学和传输特性再探讨
Am J Respir Crit Care Med. 1997 Jul;156(1):166-72. doi: 10.1164/ajrccm.156.1.9606123.

引用本文的文献

1
rhamnolipids stabilize human rhinovirus 14 virions.鼠李糖脂可稳定人鼻病毒14病毒粒子。
bioRxiv. 2025 Jun 4:2025.06.04.657910. doi: 10.1101/2025.06.04.657910.
2
The Therapeutic Potential of Myo-Inositol in Managing Patients with Respiratory Diseases.肌醇在呼吸系统疾病患者管理中的治疗潜力。
Int J Mol Sci. 2025 Feb 28;26(5):2185. doi: 10.3390/ijms26052185.
3
Rheological comparison of sputum and reconstituted airway epithelium mucus.痰液与重组气道上皮黏液的流变学比较。
Sci Rep. 2024 Dec 30;14(1):31660. doi: 10.1038/s41598-024-80932-y.
4
INSIGHTS INTO THE ORIGINS OF CYSTIC FIBROSIS LUNG DISEASE.囊性纤维化肺病的起源研究进展。
Trans Am Clin Climatol Assoc. 2024;134:29-36.
5
in chronic lung disease: untangling the dysregulated host immune response.在慢性肺部疾病中:理清失调的宿主免疫反应。
Front Immunol. 2024 Jun 28;15:1405376. doi: 10.3389/fimmu.2024.1405376. eCollection 2024.
6
Comprehensive Characterization of the Viscoelastic Properties of Bovine Submaxillary Mucin (BSM) Hydrogels and the Effect of Additives.牛颌下腺黏蛋白(BSM)水凝胶的黏弹性综合特性及添加剂的影响。
Biomacromolecules. 2024 Jul 8;25(7):4014-4029. doi: 10.1021/acs.biomac.4c00153. Epub 2024 Jun 4.
7
Mechanisms and Delivery of tRNA Therapeutics.tRNA 治疗药物的作用机制与递送。
Chem Rev. 2024 Jun 26;124(12):7976-8008. doi: 10.1021/acs.chemrev.4c00142. Epub 2024 May 27.
8
pulmonary mucus hydration assay using rotational and translational diffusion of gold nanorods with polarization-sensitive optical coherence tomography.采用偏振敏感光相干断层扫描技术对金纳米棒的旋转和平移扩散进行肺部黏液水合作用检测。
J Biomed Opt. 2024 Apr;29(4):046004. doi: 10.1117/1.JBO.29.4.046004. Epub 2024 Apr 30.
9
transcriptome analysis of metal restriction in cystic fibrosis sputum.囊性纤维化痰液中金属限制的转录组分析。
Microbiol Spectr. 2024 Apr 2;12(4):e0315723. doi: 10.1128/spectrum.03157-23. Epub 2024 Feb 22.
10
Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases.慢性呼吸系统疾病中的黏液结构、黏弹性特性和成分。
Int J Mol Sci. 2024 Feb 5;25(3):1933. doi: 10.3390/ijms25031933.